Tuberculosis (TB) remains the foremost cause of death by an infectious disease globally.
Multidrug-resistant or rifampicin-resistant TB (MDR/RR-TB; resistance to rifampicin and …

Untreated active tuberculosis (TB) has a very high long-term mortality. Treatment of TB
reduces mortality dramatically and should maximize cure, preventing ongoing transmission …

As reported by the Global Tuberculosis Network in the European Respiratory Journal,
coronavirus disease 2019 (COVID-19) has distressingly resulted in a plateauing of the …

Dear Editor, Ukraine has one of the highest TB incidences in the WHO European Region, 1
and one of the highest rates of multidrug-resistant TB (MDR-TB) worldwide. According to the …

Background Comprehensive and reliable drug susceptibility testing (DST) is urgently
needed to provide adequate treatment regimens for patients with multidrug …

Background Evaluation of novel anti-tuberculosis (TB) drugs for the treatment of multidrug-
resistant (MDR)-TB continues to be of high interest on the TB research agenda. We …

The search for novel antimicrobial agents is of huge importance. Nanomaterials can come to
the rescue in this case. The aim of this study was to assess the cytotoxicity and antimicrobial …

Objectives To describe demographics, clinical features, and treatment outcomes of patients
with highly drug-resistant tuberculosis (TB) in Ukraine, and to evaluate risk factors for an …

Background: Making a preliminary diagnosis using X-ray methods for the study of resistant
and resistant tuberculosis (TB) will help to make a preliminary diagnosis and determine …

Objective Treating and managing rifampicin resistant tuberculosis (RR-TB) patients in
Yunnan, China, are major challenges. This study aims to evaluate the risk of poor treatment …